subject area of
- <p>Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study</p> Academic Article
- <p>Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p> Academic Article
- COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada Academic Article
- Effects of a Short Course of Inhaled Corticosteroids in Noneosinophilic Asthmatic Subjects Academic Article
- Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β<sub>2</sub>-agonist fixed-dose combination: RE<sup>2</sup>SPOND rationale and study design Academic Article
- Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma Academic Article
- Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients Academic Article
- Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients Academic Article
- Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? Academic Article
- Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study Academic Article